| ²é¿´: 588 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
wqssfj1Ìú¸Ëľ³æ (ÖøÃûдÊÖ)
|
[ÇóÖú]
ÇóÖú·Òë-Ò©Æ·×¢²á×ÊÁÏÏà¹ØÄÚÈÝ
|
|
|
The efficacy conclusions are drawn primarily from the double-blind phase of the study, whereby statistically significant and clinically meaningful differences favoring BOTOX® over placebo were demonstrated for the primary efficacy endpoint and all 5 of the secondary efficacy endpoints at week 24. ÁÙ´²ÊÔÑé¸ÅÒªÏà¹ØÄÚÈÝ |
» ²ÂÄãϲ»¶
299Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
²ÄÁÏÓ뻯¹¤×¨Ë¶µ÷¼Á
ÒѾÓÐ6È˻ظ´
086500 325 Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
²ÄÁÏ080500µ÷¼ÁÇóÊÕÁô
ÒѾÓÐ7È˻ظ´
Ò»Ö¾Ô¸Äϲý´óѧ£¬327·Ö£¬²ÄÁÏÓ뻯¹¤085600
ÒѾÓÐ6È˻ظ´
»·¾³¹¤³Ìµ÷¼Á
ÒѾÓÐ9È˻ظ´
¹¤¿Æ²ÄÁÏ085601 279Çóµ÷¼Á
ÒѾÓÐ9È˻ظ´
287Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
22408 344·Ö Çóµ÷¼Á Ò»Ö¾Ô¸ »ªµç¼ÆËã»ú¼¼Êõ
ÒѾÓÐ3È˻ظ´
289Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
8814402
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 509
- Ó¦Öú: 18 (СѧÉú)
- ¹ó±ö: 0.381
- ½ð±Ò: 12916.1
- É¢½ð: 47
- ºì»¨: 16
- Ìû×Ó: 4183
- ÔÚÏß: 357.8Сʱ
- ³æºÅ: 1184404
- ×¢²á: 2011-01-06
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
2Â¥2012-09-25 08:43:31













»Ø¸´´ËÂ¥